| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $52,524,972 ) (Continued on the next page) |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K01MH127417 | Epidemiologic and Machine Learning Approaches to Frame Suicide Prevention Strategies Among Juvenile Justice Youth - 2021 | 000 | 3 | NIH | 5/8/2024 | $123,172 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA260178 | Targeting cooperative mechanisms of metastatic colonization in osteosarcoma | 001 | 3 | NIH | 6/27/2024 | $447,149 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA272872 | Understanding Infantile Rhabdomyosarcoma Biology and Therapeutic Targets | 000 | 2 | NIH | 5/8/2024 | $28,465 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NR020423 | Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention | 000 | 3 | NIH | 6/20/2024 | $625,044 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R00NR019115 | Improving adherence through mHealth for pediatric hematopoietic stem cell transplant patients | 000 | 5 | NIH | 4/29/2024 | $203,099 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01MD016064 | Racial/ethnic and geographic differences in pediatric tonsillectomy use: a multilevel investigation | 001 | 3 | NIH | 5/29/2024 | $31,873 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01MD016064 | Racial/ethnic and geographic differences in pediatric tonsillectomy use: a multilevel investigation | 000 | 3 | NIH | 1/5/2024 | $409,822 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K23HL159312 | The Development and Evaluation of Visual Communication Tools to Convey Parental and Intergenerational Cardiovascular Disease Risk and Evoke Lifestyle Behavior Change in Low-income Black Families | 000 | 3 | NIH | 5/24/2024 | $157,920 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HS028413 | Improving Quality and Outcomes for Low Income Children with Depression in the US | 000 | 3 | AHRQ | 5/9/2024 | $363,423 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01FD007532 | Phase I/II Study of 177Lu-DOTATATE in Children and Young Adults with Recurrent/Progressive High-Grade CNS Tumors and Meningiomas which Express Somatostatin Type 2A Receptors [9/24/21 IND] | 000 | 2 | FDA | 5/8/2024 | $485,894 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 Children's Drive | Columbus | OH | 43205-2664 | FRANKLIN | USA | U1V46321 | Catalysts for Infant Health Equity | 00 | 3 | HRSA | 7/12/2024 | $495,098 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | P50MH127476 | The Center for Accelerating Suicide Prevention in Real-world Settings (ASPIRES) | 001 | 3 | NIH | 7/16/2024 | $2,841,660 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K08NS119878 | Reversal of Immunoparalysis Following Traumatic Brain Injury and Systemic Hemorrhage in a Juvenile Rat Model | 000 | 3 | NIH | 4/5/2024 | $187,635 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL157208 | Transfusion and Organ Dysfunction in Pediatric Septic Shock (TROPICS) study | 001 | 3 | NIH | 6/21/2024 | $55,584 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL157208 | Transfusion and Organ Dysfunction in Pediatric Septic Shock (TROPICS) study | 000 | 3 | NIH | 3/13/2024 | $625,315 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | T32CA269052 | Training Program in Basic and Translational Pediatric Oncology Research | 001 | 3 | NIH | 6/14/2024 | $287,283 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K01DK126991 | Defining the renal urothelium progenitor and its regulation during development and repair | 000 | 4 | NIH | 5/22/2024 | $145,295 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4953004 | Healthy Start Initiative-Eliminating Racial/Ethnic Disparities | 00 | 1 | HRSA | 4/29/2024 | $880,277 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4953004 | Healthy Start Initiative-Eliminating Racial/Ethnic Disparities | 01 | 1 | HRSA | 6/6/2024 | $0 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AR078395 | CRISPR-Cas13 gene therapy and RNA editing for Facioscapulohumeral muscular dystrophy (FSHD) | 000 | 4 | NIH | 7/16/2024 | $540,811 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H79SM084968 | Expanding Access to Peritrauma and Trauma Treatment for Families in Central Ohio | 001 | 4 | SAMHSA | 7/1/2024 | $400,000 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA248103 | Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects | 000 | 4 | NIH | 2/5/2024 | $621,816 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI151175 | Immune correlates of protection against hepacivirus persistence. | 001 | 4 | NIH | 5/23/2024 | $61,483 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI151175 | Immune correlates of protection against hepacivirus persistence. | 000 | 4 | NIH | 3/7/2024 | $553,345 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA248103 | Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects | 001 | 4 | NIH | 4/17/2024 | $34,546 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD102439 | Randomized trial on mobile technology to reduce young drivers’ cellphone use | 000 | 4 | NIH | 5/31/2024 | $574,438 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H7624736 | Ryan White Part C Outpatient EIS Program | 02 | 13 | HRSA | 7/2/2024 | $0 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H7624736 | Ryan White Part C Outpatient EIS Program | 01 | 13 | HRSA | 6/4/2024 | $336,207 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H7624736 | Ryan White Part C Outpatient EIS Program | 00 | 13 | HRSA | 3/13/2024 | $112,071 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01MH123746 | THE IMPACT OF PUBERTAL SUPPRESSION ON ADOLESCENT NEURAL AND MENTAL HEALTH TRAJECTORIES - Resubmission - 1 | 000 | 4 | NIH | 5/15/2024 | $738,171 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | UH3HL148693 | A Study Evaluating the Safety and Efficacy of Second-Generation Tissue Engineered Vascular Grafts (TEVG2) | 000 | 4 | NIH | 2/12/2024 | $533,894 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL157491 | Elucidating the Molecular Mechanisms Underlying LYST-mediated Tissue Engineered Vascular Graft Stenosis | 002 | 4 | NIH | 6/22/2024 | $51,324 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL157491 | Elucidating the Molecular Mechanisms Underlying LYST-mediated Tissue Engineered Vascular Graft Stenosis | 001 | 4 | NIH | 3/4/2024 | $77,902 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL157491 | Elucidating the Molecular Mechanisms Underlying LYST-mediated Tissue Engineered Vascular Graft Stenosis | 000 | 4 | NIH | 3/1/2024 | $577,406 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155282 | An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | 003 | 4 | NIH | 2/7/2024 | -$77,578 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155282 | An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | 002 | 4 | NIH | 1/25/2024 | $77,578 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155282 | An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | 001 | 4 | NIH | 1/24/2024 | $114,128 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155282 | An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | 000 | 4 | NIH | 1/19/2024 | $385,000 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DA052580 | Evaluating the impact of fentanyl test strip use among rural and urban populations | 000 | 4 | NIH | 4/23/2024 | $667,241 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U24CA254445 | (EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank | 000 | 5 | NIH | 5/31/2024 | $1,758,352 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DK125469 | Novel roles for urothelium during urinary tract obstruction | 000 | 5 | NIH | 6/13/2024 | $418,133 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL153406 | Cardiac regeneration by histone deacetylases | 000 | 6 | NIH | 6/26/2024 | $390,000 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DK122171 | Aerodigestive Pathophysiology-Driven Mechanisms of Infant Feeding Difficulties | 000 | 5 | NIH | 6/13/2024 | $490,566 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AA027502 | Therapeutic roles of hepatocyte exosomes in the liver | 001 | 5 | NIH | 5/22/2024 | $40,984 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AA027502 | Therapeutic roles of hepatocyte exosomes in the liver | 000 | 5 | NIH | 2/23/2024 | $368,855 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD100493 | Long-term Effects and Safety of DHA Supplementation in Toddlerhood for Children born Preterm | 000 | 5 | NIH | 7/12/2024 | $571,848 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA262873 | Mdm2 Alternative Splicing in DNA Damage and Cancer | 000 | 3 | NIH | 6/27/2024 | $31,249 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DE028296 | Redox Regulation of Gingival Inflammation | 003 | 6 | NIH | 6/12/2024 | $35,339 |
| 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DE028296 | Redox Regulation of Gingival Inflammation | 000 | 6 | NIH | 11/6/2023 | $397,564 |
|